Berlin, Germany 1 October 2025 – Boehringer Ingelheim RCV has expanded its partnership with Clariness, launching its patient recruitment on the marketplace model of ClinLife® in Bulgaria, Israel and Romania.
This expansion builds upon an existing strategic partnership that has seen Clariness host more than 30 Boehringer Ingelheim RCV studies in 5 countries since 2021, supporting crucial indications including depression, hidradenitis suppurativa, systemic sclerosis, schizophrenia as well as solid tumors, lung cancer and more.
Speaking on the expansion, Hermann Novak, Regional Therapeutic Area Lead CNS, Retinopathies and Emerging Areas at Boehringer Ingelheim RCV, commented, “We are always looking to innovate how we engage patients on a local level, and being able to do so with a proven partner, ensures we do so with the best patient journey possible.”
Moritz Kloss, SVP Local Markets & Initiatives at Clariness, said, “This expansion is testament to the great partnership we have, and the versatility of ClinLife®. These 3 countries have varying regulatory frameworks, healthcare models, focus indications and more, and we look forward to servicing these patient populations in Bulgarian, Hebrew, and Romanian.”
As Clariness continues to grow its partnership with Boehringer Ingelheim, Clariness will be engaging healthcare professionals, research sites, and patient advocacy groups in these new regions to accelerate access to clinical trials and advancing medical research together.
–ENDS–
About Boehringer Ingelheim RCV
The Boehringer Ingelheim Regional Center Vienna (RCV) oversees business with human and animal health products. Apart from Austria, the region comprises over 30 countries, primarily in Central and Eastern Europe and Central Asia.
Clinical research in the entire region is coordinated from Vienna. The RCV Campus is also the central site for cancer research and biopharmaceutical research and production. The company has 4,940 employees in the region, including 3,451 in Austria.
Learn more at: www.boehringer-ingelheim.com/at
About Clariness
Clariness provides high-end services across the clinical trial lifecycle, including study feasibility, patient recruitment, and patient retention services, for pharmaceutical companies, contract research organizations (CROs), and study sites across the globe. Dedicated to improving patients’ lives by accelerating the development of medical treatments and therapies, Clariness is the leading expert in global patient recruitment with 20 years’ experience. Clariness has supported over 1,500 clinical trials worldwide through its market leading patient portal ClinLife®, which is active in 50+ countries, available in 35+ languages, covers 175+ indications, and welcomes 15+ million visitors per year. For more information, visit www.clariness.com and www.clinlife.com.
About ClinLife®
ClinLife® is a patient-friendly digital platform that allows users to browse indications, find matching clinical studies and apply for them via the portal. Different sponsors, sites, CROs and digital health applications list a single study or an entire portfolio of clinical trials on ClinLife®.
Press Contact: Joseph Yeomans, SVP Marketing & Growth, [email protected]
